Core Insights - Recently, China Resources (Chengdu) Pharmaceutical Industry Equity Investment Fund Partnership (Limited Partnership) was established with a capital contribution of 1 billion RMB, focusing on venture capital [1] Group 1: Fund Establishment - The fund's executive partner is China Resources Pharmaceutical Technology (Chengdu) Partnership (Limited Partnership) [1] - The fund is co-funded by Chengdu Major Industrialization Project Phase II Equity Investment Fund Co., Ltd., Boya Bio (300294), Dong-E E-Jiao (000423), China Resources Double Crane (600062), and Jiangzhong Pharmaceutical (600750) [1] Group 2: Strategic Focus - In July, several listed companies under China Resources announced plans to jointly invest in the establishment of China Resources Pharmaceutical (Chengdu) Innovation Investment Fund Partnership (Limited Partnership) with Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. and Chengdu state-owned enterprises [1] - The focus of this new fund will be on the pharmaceutical health main business and strategic emerging industries [1]
华润等在成都成立医药产业股权投资基金 出资额10亿
Xin Lang Cai Jing·2025-11-10 03:48